יום חמישי, י״ד אלול תשפ״וThursday, August 27, 2026
Follow Us
Tel Aviv University researchers have developed a biological substitute for the treatment of tuberculosis, which in the future could serve as an alternative for the traditional "chemical" antibiotic therapy.
Invasive fungal infections of the internal organs or bloodstream can have a high level of mortality (up to 50%), are often difficult to treat, and cause at least 1.6 million deaths per year.
August 28, 2026 
